Disease Information
General Information of the Disease (ID: DIS00011)
Name |
Typhoid fever
|
---|---|
ICD |
ICD-11: 1A07
|
Resistance Map |
Type(s) of Resistant Mechanism of This Disease
ADTT: Aberration of the Drug's Therapeutic Target
Drug Resistance Data Categorized by Drug
Approved Drug(s)
2 drug(s) in total
Ciprofloxacin XR
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Key Molecule: DNA gyrase subunit A (GYRA) | [1] | |||
Resistant Disease | Typhoid fever [ICD-11: 1A07.0] | |||
Molecule Alteration | Missense mutation | p.S83F |
||
Resistant Drug | Ciprofloxacin XR | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica subsp. enterica serovar Typhi isolates | 90370 | ||
Experiment for Molecule Alteration |
PCR-RFLP | |||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | The targets of fluoroquinolones are the two enzymes, DNA gyrase and topoisomerase IV, whose subunits are encoded respectively by gyrA and gyrB and the parC and parE genes.The alteration caused by single point mutations within the QRDR of the DNA gyrase subunit gyrA gene leads to quinolone resistance. |
Nalidixic acid
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Key Molecule: DNA topoisomerase 4 subunit A (PARC) | [1] | |||
Resistant Disease | Typhoid fever [ICD-11: 1A07.0] | |||
Molecule Alteration | Missense mutation | p.W106G |
||
Resistant Drug | Nalidixic acid | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Salmonella enterica subsp. enterica serovar Typhi isolates | 90370 | ||
Experiment for Molecule Alteration |
PCR-RFLP | |||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | The targets of fluoroquinolones are the two enzymes, DNA gyrase and topoisomerase IV, whose subunits are encoded respectively by gyrA and gyrB and the parC and parE genes.The alteration caused by single point mutations within the QRDR of the DNA gyrase subunit gyrA gene leads to quinolone resistance. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.